Skip to main content

Table 1 Baseline characteristics of all patients with pancreatic cancer

From: Time interval-based indication for liver resection of metastasis from pancreatic cancer

   (n = 79)
Age (years) 66 (41–83)
Primary operation (%)  
pancreaticoduodenectomy   50 (63.3)
 Distal pancreatectomy   28 (35.4)
 Total pancreatectomy   1 (1.3)
TMN classification stage (%)  
 IA   4 (5.1)
 IB   6 (7.6)
 IIA   24 (30.4)
 IIB   18 (22.7)
 III   26 (32.9)
 IV   1 (1.3)
Serum bilirubin (IU/L) 0.69 (0.2–11.7)
Serum albumin (IU/L) 4.0 (3.5–4.9)
Carcinoembryonic antigen (IU/L) 3.85 (0.6–255)
Carbohydrate antigen 19-9 (IU/L) 104.9 (0.1–13,820)
Operation time (min) 446 (193–738)
Intraoperative blood loss (ml) 370 (25–1720)
Adjuvant chemotherapy after pancreatectomy (%) 20 (25)
  1. Values represent median with range